Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
13Dec2025
  • Home
  • About
  • News
  • Subscribe
13Dec2025
Cost Curve NewsCost Curve News
Cost Curve News

Does RFK Jr. Support March-In Rights? Thinking Through the Either/Ors

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
11 months ago
Keep Reading
Cost Curve News

A Decision in the Lawsuit Over J&J’s Health Benefit Dents (Maybe) One Avenue to PBM Reform

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
11 months ago
Keep Reading
Cost Curve News

Some Final Thoughts from #JPM25 (on Meeting the Moment and Hospital Finances)

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
11 months ago
Keep Reading
Cost Curve News

What State and Local Governments Can Teach Us About Understanding of 340B

This was not the week I was promised, so it’s a late-arriving Curve today. Your patience, as always, is appreciated. I’m about to throw a whole bunch of links to
11 months ago
Keep Reading
Cost Curve News

ICER Is Tackling Launch Pricing. I’m Wishing Them Luck. They’ll Need It.

Fair warning: the rest of the week might be heavy on 340B. It’s a topic that is very hip, very 2025. ICER has decided that its next big research effort
11 months ago
Keep Reading
Cost Curve News

A Brief Reminder: Medicare ‘Negotiations’ Alone Don’t Really Save Money for Seniors

It’s Beanpot championship day, sportsfans. Go Terriers. Welcome to Day Two of Trump 2.0. This is probably a good time to expound on how I’m going to approach news coming
11 months ago
Keep Reading
Cost Curve News

A Roundup of How Pharma Companies Responded to the Medicare Drug ‘Negotiation’ Announcement Last Week

It’s inauguration day today, and I have no great insights on what is to come from a health policy POV. So I will repeat my standard mantra/gif about what’s next:
11 months ago
Keep Reading
Cost Curve News

And We’re Off: The Next 15 Drugs Up for Medicare ‘Negotiations’ Have Been Announced

Well, this is a fitting end to a wild week. We now have the 15 medicines that will go through the next round of price-setting “negotiations” with CMS. Here are
11 months ago
Keep Reading
Cost Curve News

At the Risk of Repetition: It Was Another Quarter of Record Profits for United’s PBM Unit

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
11 months ago
Keep Reading
Cost Curve News

Hoo Boy, What a Day: An FTC PBM Report, NYT Goes Deep on 340B, #JPM25 Stuff, and More

So. Much. To. Cover. Today.   If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at
11 months ago
Keep Reading
212223

Latest Posts

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

December 8, 2025

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

December 5, 2025

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

December 4, 2025

Popular

A New Tracker for Watching Meds That Might See Prices Slashed

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,939)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,029)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,921)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,717)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,709)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe